Description
The Enzo Life Sciences BML-P209-0001 is a high-quality MLCK Inhibitor, specifically targeting the MLCK (342-352) sequence. This peptide-based inhibitor is designed for research applications requiring precise control over MLCK activity. Manufactured by Enzo Life Sciences, it ensures reliable performance in biochemical assays and studies related to muscle contraction and other physiological processes regulated by MLCK.
- MLCK Inhibitor (342-352) amide
- Peptide-based formulation
- High purity for research applications
Explore the potential of this advanced inhibitor for your research needs today!
Reviews
There are no reviews yet.